MAM
Sebamed unveils new campaign #pHmatters for their Hair Care portfolio
Mumbai: Sebamed, German personal care brand with a legacy of over 60 years, has announced the launch of its latest integrated campaign #pHmatters. The campaign re-affirms Sebamed’s commitment to highlight the importance of using pH 5.5 based products for healthy hair and skin. Sebamed products are made of highest quality ingredients with pH 5.5 benefits and are known worldwide to be highly efficacious backed by robust scientific research.
The campaign #pHmatters leverages tongue in cheek humour, to highlight the importance of the role of pH 5.5 based products for healthy hair and scalp. In the campaign the spotlight shines on Sebamed’s Anti- Hairloss Shampoo with pH 5.5 and highlights its importance for healthy scalp and hair and its impact of good hair in consumer’s life. The campaign features a series of multilingual films in languages such as Hindi, English, Kannada, Marathi, Tamil, Telugu and Malayalam to reach consumers across India. To further boost the campaign’s reach and build excitement, the brand will also be promoting it across all media platforms including TV, Digital, social media, Print, Movie screens and out-of-home.
Sebamed president – USV Consumer Products Shashi Ranjan said, “We are a purpose driven organization that has constantly challenged the convention and redefined the perspectives in the realm of personal care with singular focus on bringing positive impact in the lives of our consumers. #pHmatters campaign stands as a testament to our commitment, as we highlight the importance of pH 5.5 for healthy hair and scalp basis evidence-based science. As a brand committed to transparency and authenticity, we invite our audiences to join the conversation on the importance of pH 5.5 for healthy hair and skin.”
Sebamed category head Abhinav Sebamed shared, “The launch of our new #pHmatters campaign reaffirms our commitment to enable consumers with new knowledge backed by science. The #pHmatters campaign leverages tongue in cheek humour to land the point that hair plays a very important role in our consumers life and pH 5.5 based hair care products help in maintaining healthy hair and scalp. The campaign highlights the criticality of using pH 5.5 based products for healthy hair and urges consumers to switch to Sebamed range of hair care products with perfect pH5.5.”
The Womb creative head Suyash Khabya said, “The campaign has a unique presentation of humour, without trying too hard. It’s simple yet unignorable. In an absurdist situation of a funeral, a father is eulogising his son. However, as the ad progresses things take an interesting turn as he starts speaking about ‘regrets’ in the same breath as ‘hair loss’. The plot is engaging and the brand messaging bang on. Apart from the master film, there are interesting, witty 10 seconders, an OOH campaign and more digital ideas.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
